Introduction
The small GTPase Ras is frequently mutated in cancer and contributes to transformation and tumor progression (Dunn et al., 2005; Tan et al., 2005) . Physiologically, Ras is involved in a variety of signaling pathways regulating different outcomes (Cordova-Alarcon et al., 2005) . Guanosine-triphosphate-loaded Ras activates many pathways, including the mitogen-activated protein kinase/extracellular-signal-regulated kinase (MAPK/ ERK) pathway, the PI3 kinase pathway and the RalGDS pathway, all of which have known roles in cancer via diverse effects both on a cellular and physiological level. For example, Ras/MAPK/ERK signaling modulates transcription, cell cycle progression, proliferation and differentiation, as well as senescence and cell death (Ramos, 2008; Castaneda et al., 2010; Ferro and Trabalzini, 2010) .
Mutations in Ras genes such as K-Ras, N-Ras or H-Ras can be found in various tumors and are often associated with poor prognosis (Cordova-Alarcon et al., 2005; Zeng et al., 2010) . Mutated H-Ras is associated with elevated expression of key cell cycle regulatory proteins, such as cyclin D1 and cdk4, in in vivo models of oral squamous-cell carcinoma of the head and neck region (Sathyan et al., 2007) . Cordova-Alarcon et al. (2005) showed that mutational activation of H-Ras accelerates G1/S cell cycle transition in a human cervical cancer-derived cell line in vitro and has an important role in the development of cervical tumors. Oncogenic H-Ras also transforms NIH3T3 fibroblasts, at least in part, through upregulation of cyclin D1 due to an overexpression of Kruppel-like factor 5 (Nandan et al., 2004) . Interestingly, mutations in H-Ras not only affect gene transcription but also contribute to tumor cell transformation by inducing anti-apoptotic signals. In immortal baby mouse kidney epithelial cells (iBMK), a constitutively activated form of H-Ras inhibited paclitaxel-induced accumulation of the proapoptotic BH3-only protein BIM, thereby preventing BIM-dependent apoptosis. In this model, H-Ras to ERK signaling resulted in phosphorylation of BIM, leading to its proteasomal degradation (Tan et al., 2005) .
The small death effector domain-containing protein phosphoprotein enriched in astrocytes, 15 kDa (PEA-15) is a molecular scaffold that regulates several pathways including the Ras/MAPK/ERK signaling cascade (Ramos, 2008; Revet et al., 2008) . It has been shown to bind to ERK and prevent ERK-mediated gene transcription (Formstecher et al., 2001; Whitehurst et al., 2004) . This can result in a downregulation of cell proliferation, as shown in murine T cells (Pastorino et al., 2010) . Interaction of PEA-15 with specific partners is controlled by its phosphorylation and subcellular localization. These factors therefore determine the effects of PEA-15 on cellular signaling processes (Renganathan et al., 2005) . Phospholipase D (PLD) binds to PEA-15 and is a widely expressed enzyme that catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid (PA) and choline (Wang et al., 1999; Yang et al., 2001) . Although the physiological function of this interaction remains elusive, PEA-15 stabilizes PLD expression and may activate it by a yet undefined mechanism (Zhang et al., 2000) . PLD has been shown to modulate the Ras-ERK pathway and regulate the cell cycle and cell proliferation (Yang et al., 2001; Donaldson, 2009 ). PLD activity is crucial for Ras activation in NIH3T3 cells, where PLD-produced PA is necessary for the recruitment of son of sevenless (SOS), a direct activator of Ras, to the membrane (Zhao et al., 2007) . In addition, in Rat-1 fibroblasts PA can associate with Raf-1 and target it to the membrane. This Ras-independent recruitment is important for the subsequent activation of Raf-1 by Ras in these cells and is required for further downstream signaling (Rizzo et al., 2000) . Elevated PLD activity is found in several tumors, including breast, gastric and renal cancers (Uchida et al., 1997 (Uchida et al., , 1999 Noh et al., 2000; Zhao et al., 2000) . PLD has also been shown to have transforming properties in fibroblasts with aberrant tyrosine kinase activity and may contribute to tumor progression in this context (Lu et al., 2000; Joseph et al., 2001) . Furthermore, in v-Raf transformed NIH3T3 cells, increased PLD activity was able to overcome Raf-induced cell cycle arrest (Frankel et al., 1999; Joseph et al., 2002) .
In this study, we analyzed the effects of PEA-15 expression on H-Ras-transformed mouse kidney epithelial cells (iBMK) . Surprisingly, we found that PEA-15 does not block H-Ras proliferation signals as previously described, but in this cellular context enhanced H-Rasdriven transformation independent of apoptosis. Coexpression of H-Ras and PEA-15 resulted in enhanced tumor formation in vivo and increased colony formation in soft agar assays in vitro. Analysis of the cell cycle in iBMK cells revealed an accelerated G1/S cell cycle progression when both proteins were expressed. In this context activity of the Ras/MAPK/ERK signaling pathway as well as the expression of major cell cycle regulatory proteins were elevated. At the same time, expression of both H-Ras and PEA-15 caused an increase in PLD1 expression and activity compared with the expression of H-Ras alone. Finally, treatment of these cells with inhibitors of PLD1 or expression of a PLD1 mutant preventing binding to PEA-15 blocked activation of the ERK/MAPK pathway. We have thus identified a novel mechanism by which PEA-15 can positively regulate Ras/ERK/MAPK signaling and increase the proliferation of H-Ras-transformed epithelial cells. The enhancement of Ras signaling was in part due to increased activity of PLD1 resulting from PEA-15 expression. This is the first evidence to link PEA-15 regulation of Ras signaling to effects on PLD.
Results
PEA-15 enhances H-Ras-mediated epithelial cell transformation in vitro in an adhesion-independent manner Expression of oncogenic H-Ras leads to a transformed phenotype in iBMK cells, resulting in adhesionindependent colony formation in soft agar assays (Degenhardt and White, 2006) . PEA-15 negatively regulates H-Ras to ERK signaling and blocks H-Ras-mediated proliferation signals by sequestering ERK in the cytoplasm (Formstecher et al., 2001; Pastorino et al., 2010) . The ability of cells to grow in suspension is a hallmark of transformation. We therefore analyzed whether co-expression of PEA-15 would abolish H-Ras-mediated transformation in iBMK cells and inhibit Ras-induced growth in soft agar assays. Surprisingly, stable co-expression of PEA-15 in the presence of active H-Ras enhanced soft agar colony growth. Cells stably overexpressing both H-Ras and PEA-15 formed significantly (Po0.0003) more colonies in soft agar compared with cells expressing H-Ras alone (Figure 1a) . Neither the control cell lines nor the cell lines stably expressing PEA-15 alone were able to form soft agar colonies. Co-expression of PEA-15 in cells expressing the constitutively active form of H-Ras not only augmented the number of soft agar colonies formed, but also increased the diameter of the colonies (Figures  1b and c) . We verified the overexpression of PEA-15 and H-Ras after stable transfection by immunoblot (Figure 1d ).
PEA-15 promotes G1-to S-phase transition and does not alter anoikis
The Ras/MAPK/ERK signaling cascade has been shown to be involved in the regulation of cell cycle progression both in physiological and pathological conditions (Cordova-Alarcon et al., 2005; Sathyan et al., 2007; Viparelli et al., 2008) . We therefore analyzed whether the increased colony formation in soft agar was due to influences of PEA-15 expression on cell cycle regulation. Interestingly, suspended iBMK cells stably expressing both H-Ras and PEA-15 had fewer cells at the G0/G1 phase and significantly increased cells in the S and mitotic phases compared with H-Ras expression alone. Cell lines stably expressing PEA-15 alone showed a decreased number of cells in G0/G1 compared with the control cell line, but no significant differences could be observed in S and M phases (Figures 2a and b) .
Previous reports indicate that PEA-15 can enhance tumorigenesis by inhibiting apoptosis (Formisano et al., 2005) . Therefore, we investigated whether stable PEA-15 expression in iBMK cells would lead to protection from anoikis. In suspension, PEA-15 expression did not alter anoikis significantly compared with control cell lines, as shown by the percentage of dead cells. The stable expression of H-Ras significantly decreased the number of cells undergoing anoikis. However, no significant differences were observed between cells stably expressing H-Ras alone and cells expressing both H-Ras and PEA-15 (Figure 2c ).
PEA-15 alters expression of cell cycle regulatory proteins
The observed differences in the cell cycle of stably transfected iBMK cell lines in suspension led us to analyze the expression levels of ERK-regulated cell cycle proteins in these cells. As previously reported, H-Ras enhanced cyclin D expression levels compared with control cell lines (Lovec et al., 1994; Lavoie et al., 1996; Nandan et al., 2004) . Cells stably expressing both H-Ras and PEA-15 had a slight increase in cyclin D expression levels compared with cells expressing H-Ras alone. PEA-15 expression alone slightly induced cyclin D1 expression compared with control cells (Figure 3a) .
The cyclin-dependent kinase cdk4 is an important binding partner for cyclin D and is necessary for G1-S transition (Connell-Crowley et al., 1997). As described previously, H-Ras transiently decreases cellular cdk4 expression (Lazarov et al., 2002;  Figure 3a) . Moreover, PEA-15 expression alone slightly lowered cdk4 levels when cells were in suspension. Interestingly, PEA-15 was able to maintain cdk4 expression when coexpressed with H-Ras in suspended cells (Figure 3a) . PEA-15 enhances H-Ras-mediated cell transformation FJ Sulzmaier et al PEA-15 increases activation and expression levels of ERK/MAPK pathway members The Ras-MAPK cascade is closely integrated into the regulation of the cell cycle and can influence the expression and activity of cell cycle regulatory proteins (Viparelli et al., 2008) . In addition, PEA-15 has been shown to regulate the ERK/MAPK signaling pathway (Formstecher et al., 2001; Pastorino et al., 2010) . Intriguingly, PEA-15 also potentiates Ras activation of ERK by an adhesion-independent mechanism . We therefore analyzed whether the changes in cyclin D and cdk4 expression coincide with increased ERK signaling in the stably transfected iBMK cell lines. We determined the activation and expression levels of ERK, its cytoplasmic target RSK2 and the nuclear ERK target Elk-1. PEA-15 and H-Ras individually as well as in combination were able to activate ERK equally in adherent cells as reported previously (not shown; Ramos et al., 2000; Haling et al., 2010) . Interestingly, cells in suspension stably expressing both H-Ras and PEA-15 showed higher ERK activation compared with cell lines expressing H-Ras or PEA-15 alone (Figure 3a) . Expression levels of ERK were unaltered in all iBMK cell lines (Figure 3a) . Transiently transfected cells in suspension showed similar results ( Figure 3b ). Transfection of H-Ras alone induced phosphorylation of ERK, and co-transfection of PEA-15 further enhanced this effect. Indeed, the more PEA-15 transfected, the greater the increase in phosphorylated ERK (pERK; Figure 3b ).
In parallel to our previous reports, we observed differences in the phosphorylation of the cytoplasmic ERK target RSK2 in the different iBMK cell lines (Vaidyanathan et al., 2007) . Suspended cells stably coexpressing H-Ras and PEA-15 showed enhanced RSK2 phosphorylation compared with cells expressing H-Ras alone ( Figure 3a) . However, PEA-15 overexpression alone also augmented RSK2 phosphorylation compared with control cell lines in suspension. PEA-15 expression not only increased phosphorylation of RSK2, but also caused a modest increase in RSK2 expression when cells were in suspension.
Elk-1 is a nuclear target of ERK in Ras-MAPK signaling. We previously reported that PEA-15 can restrict ERK to the cytoplasm and prevent phosphorylation of nuclear targets in astrocytes and T lymphocytes (Formstecher et al., 2001; Pastorino et al., 2010) . As expected, expression of oncogenic H-Ras alone increased phosphorylation of Elk-1 in suspended stably transfected iBMK cells (Figure 3a) . Surprisingly, coexpression of PEA-15 and H-Ras further enhanced the phosphorylation of Elk-1 in these cells. No phosphorylation was detected when only PEA-15 was expressed. 
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FJ Sulzmaier et al phosphorylation of ERK, in part, by inhibiting a feedback loop that inactivates the Ras/MAPK pathway (Haling et al., 2010) . In contrast, our results showed that transfection of PEA-15 in iBMK cells expressing active H-Ras increases phosphorylation of ERK (Figures 3a and b). We therefore sought to determine whether PEA-15 is capable of activating ERK independent of prior activation of the Ras/Raf signaling cascade. We analyzed the effects of inducible PEA-15 expression in transiently transfected CHO cells in which Ras/MAPK signaling was shut down through starvation. Starvation of the cells resulted in the expected shut down of Ras-MAPK signaling as seen in the absence of pERK in the vector control. Starvation of the cells did not alter the phosphorylation of ERK when a constitutively active form of Raf was transfected or PEA-15 was constitutively overexpressed. Importantly, induction of PEA-15 by ponasterone in the serum-starved cells resulted in ERK activation to a similar level as the constitutively active controls ( Figure 3d ). Minimal activation of ERK was observed in the absence of ponasterone induction likely due to low uninduced expression of PEA-15 in these cells.
PEA-15 is phosphorylated at Ser116 and does not sequester ERK in the cytoplasm when co-expressed with constitutively active H-Ras
The elevated level of phosphorylated Elk-1 in cells stably co-expressing H-Ras and PEA-15 led us to the conclusion that in these cells PEA-15 is not able to prevent phosphorylation of nuclear ERK targets, as described previously in other cell types (Formstecher et al., 2001; Whitehurst et al., 2004; Pastorino et al., 2010) . PEA-15 loses its ability to bind to ERK upon phosphorylation at serine 116 (Ser116; Renganathan et al., 2005) . We therefore analyzed the phosphorylation status of PEA-15 at Ser116 in PEA-15-expressing iBMK cell lines. All three independent cell lines stably coexpressing H-Ras and PEA-15 showed phosphorylation of PEA-15 at Ser116 (Figure 4a ). Minimal phosphorylation at this site was observed in cells expressing PEA-15 alone. The presence of PEA-15 in all cell lines was confirmed by immunoblotting for total PEA-15. To confirm that the phosphorylation at Ser116 resulted in a loss of the ability to sequester ERK in the cytoplasm, we analyzed the cellular localization of ERK by immunofluorescence staining of the stably transfected iBMK cells. In cells expressing PEA-15 alone, ERK was localized predominantly in the cytoplasm as previously reported (Figure 4b) . The expression of H-Ras alone led to an increased translocation of ERK into the nucleus. PEA-15 co-expression with H-Ras did not alter the translocation. In these cells, ERK was found both in the cytoplasm and the nucleus, with a slightly higher concentration of nuclear ERK (Figure 4b ).
Ser116 phosphorylation of PEA-15 is necessary for its enhancing effect on H-Ras-induced activation of ERK The finding that PEA-15 is phosphorylated at Ser116 when stably co-transfected with H-Ras into iBMK cells 
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made us further analyze the importance of this phosphorylation for the enhancement of H-Rasmediated cell transformation. We analyzed the ability of a constitutively unphosphorylated PEA-15 mutant (S116A) to increase H-Ras-induced activation of ERK. This mutant has an amino-acid substitution at the Ser116 phosphorylation site that prevents phosphorylation. In a transient system, we transfected iBMK cells with H-Ras in combination with wild-type PEA-15 or the Ser116 phosphorylation-deficient (S116A) mutant. As expected transfection of H-Ras increased activation of ERK. PEA-15 co-transfection further enhanced this effect. Interestingly, co-transfection of S116A failed to show significant enhancement of the H-Ras-induced pERK elevation (Figure 4c ). Levels of activated ERK were still higher than in control cells, but not significantly increased compared with H-Ras-onlyexpressing cells.
PEA-15 increases PLD1 expression and activity PEA-15 does not appear to block a feedback loop that negatively regulates ERK in iBMK cells and so an alternative mechanism must explain the increased ERK activity. PEA-15 also binds to and stabilizes PLD1, and can lead to increased PLD activity (Zhang et al., 2000) . PLD1 is involved in regulating both Ras-MAPK signaling and cell cycle progression (Yang et al., 2001; Donaldson, 2009) . PLD1 therefore was a promising candidate to mediate PEA-15's effects on ERK activity and cyclin D/cdk4 expression. In transiently transfected iBMK cells, expression of H-Ras doubled the amount of PLD1 compared with control cells (Figure 5a ). Co-expression of both PEA-15 and H-Ras further enhanced this effect and resulted in a more than 3-fold higher expression compared with the control cell line and 1.5-times higher than in cells expressing only H-Ras. Transient overexpression of PEA-15 and H-Ras also affected PLD1 activity. H-Ras and PEA-15 both individually as well as in combination increased the PLD1 activity of iBMK cells compared with control cells (Figure 5b ). Co-expression of PEA-15 and H-Ras resulted in higher PLD1 activity increases than H-Ras expression alone.
PEA-15 co-localizes with PLD1
PEA-15's ability to regulate PLD1 expression levels or activity has been shown to be dependent on the interaction of these two proteins, and targeting this interaction can impair PLD1 functions (Zhang et al., 2000; Viparelli et al., 2008) . We analyzed the expression pattern of PLD1 and PEA-15 in iBMK cells stably expressing PEA-15 or H-Ras and PEA-15 to analyze H-Ras-mediated effects on the localization of these proteins and to determine their co-localization. Immunofluorescence images showed a similar pattern of expression of both proteins (Figure 5c ). High levels of PLD1 and PEA-15 could be found in the nuclear and cytoplasmic regions surrounding the nucleus. The proteins co-localize in those regions (yellow color) and that is independent from H-Ras expression. Upon PEA-15 enhances H-Ras-mediated cell transformation FJ Sulzmaier et al overexpression of H-Ras, both PEA-15 and PLD1 can be found in patches in the cell membrane in addition to the nuclear and perinuclear localization. Within these spots, both proteins co-localize as seen in the magnified images ( Figure 5c , right panel).
Inhibition of PLD1 reduces PEA-15-induced increase in ERK activation
To verify that PEA-15's influence on ERK activation is mediated through PLD1, we inhibited PLD1 and analyzed the effects on PEA-15-mediated activation of ERK. PLD was either inhibited with n-butanol or a small-molecule inhibitor (VU 0155069) that has been described previously to selectively inhibit enzyme function of the PLD1 isoform (Scott et al., 2009) . To evaluate the effects of this treatment on ERK activation, we analyzed the phosphorylation status of ERK by immunoblotting. Transient expression of either PEA-15 or H-Ras resulted in elevated levels of pERK compared with control cells (Figure 6a ). Co-expression of both proteins increased ERK activation even further than either protein individually. Treatment with either PLD1 inhibitor VU 0155069 or n-butanol impaired pERK in cells transiently transfected with PEA-15, H-Ras or both proteins. The greatest effects were observed in cells expressing both PEA-15 and H-Ras, where the inhibitor treatment resulted in about 60% less ERK activity. Both inhibitors had similar effects on the treated cell lines (Figure 6a ). To exclude cytotoxic effects as the main reason for the decreased ERK activation, we analyzed the impacts of the PLD1 inhibitor VU 0155069 on the cell viability. Staining of VU-treated iBMK cells with propidium iodide showed only a slight decrease in cell Inhibition of PLD1 inhibits soft agar colony formation As shown before, oncogenic H-Ras is able to transform iBMK cells (Degenhardt and White, 2006) . We analyzed whether PLD1 activity is necessary for this transformation. We determined the effect of PLD1 inhibitor on soft agar colony formation using stably transfected iBMK cells. As previously shown, cells expressing H-Ras were able to form colonies independent from adhesion to a substrate, and PEA-15 co-expression greatly magnified this effect (Figure 6c) . Pretreatment of cells with the PLD1-specific inhibitor VU 0155069 significantly inhibited the formation of colonies in cells expressing PEA-15 and H-Ras.
Binding of PEA-15 to PLD1 is required for PEA-15's effect on H-Ras-mediated enhancement of ERK activity PEA-15 can bind to PLD1, and it has been shown that disruption of the PEA-15-PLD1 interaction can impair downstream PLD1 effects such as PKC-a activation (Viparelli et al., 2008) . These findings in addition to our finding that PLD1 co-localizes with PEA-15 in iBMK cells raised the question whether binding of the two proteins is necessary for the observed enhancement of ERK activity in H-Ras-expressing iBMK cells. The PEA-15 binding region of PLD1 has already been mapped to a C-terminal domain D4 (AA 712-1074) and the residues 762-801 within this domain have been identified as the shortest PEA-15-binding segment (Figure 7a ; Zhang et al., 2000; Doti et al., 2010) . Here, we used a PLD1 construct only consisting of the D4 domain ( Figure 7b ) and lacking catalytic activity (PLD1-D4). When overexpressed, this construct competes with the endogenous PLD1 and keeps it from binding to PEA-15. We analyzed whether transient overexpression of this mutant in addition to transient expression of H-Ras and PEA-15 would affect the previously observed changes in pERK. Without overexpression of mutant PLD1-D4, H-Ras expression led to increased ERK activation and PEA-15 enhanced this effect as expected (Figure 7a) . Interestingly, co-expression of PLD1-D4 prevented the increase in pERK upon H-Ras and PEA-15 co-transfection. pERK levels in these cells are not significantly different from cells only expressing H-Ras. There was no statistically significant effect of the PLD-D4 mutant on H-Ras-only-transfected cells (Figure 7a ). Previous reports have shown the ability of H-Ras to contribute to cell transformation. Ras has been reported in various cell types to affect transcription, drive cell cycling and proliferation or to block apoptosis and anoikis (Macaluso et al., 2002; Cordova-Alarcon et al., 2005; Viparelli et al., 2008) . Degenhardt and White (2006) described that overexpression of constitutively active H-Ras (G12V) is enough to transform iBMK cells. H-Ras promotes the proteasomal degradation of the proapoptotic Bcl-2 family protein BIM through the Raf/MAPK pathway in these cells (Tan et al., 2005) .
Conversely, PEA-15 has generally been described to block Ras/MAPK-mediated gene transcription and to inhibit proliferation by sequestering ERK in the cytoplasm (Formstecher et al., 2001; Pastorino et al., 2010) . Moreover, in ovarian cancer cells PEA-15 has been shown to exert tumor-suppressive effects, at least in part, through induction of ERK-dependent autophagy. However, the mechanism of PEA-15's involvement is not fully understood and it is unclear whether H-Ras signaling is involved in this regulation (Bartholomeusz et al., 2008) .
In contrast to reports suggesting a tumor-suppressor function of PEA-15, our findings confirm that PEA-15 expression can also potentiate ERK activation as we have previously described . However, oncogenic H-Ras expression remains necessary for full transformation, as overexpression of PEA-15 alone 
PEA-15 enhances H-Ras-mediated cell transformation FJ Sulzmaier et al
did not lead to a transformed phenotype. PEA-15 overexpression in iBMK cells prevents ERK translocation to the nucleus as previously reported (Formstecher et al., 2001) . However, when co-transfected with H-Ras, we could not observe this effect. ERK is not sequestered in the cytoplasm and can translocate into the nucleus. This is likely due to phosphorylation of PEA-15 at Ser116, a phosphorylation that decreases PEA-15's binding to ERK (Renganathan et al., 2005) . A phosphorylation-deficient mutant of PEA-15 was not able to further enhance H-Ras-driven enhancement of ERK activity. Thus, phosphorylation at Ser116 is required for PEA-15 effects on H-Ras/ERK MAP kinase signaling. Ras-ERK signaling is regulated through a system of positive and negative feedback loops (Ramos, 2008) . Haling et al. (2010) reported that PEA-15 can increase ERK activation by interrupting a negative feedback loop in which ERK phosphorylates fibroblast receptor substrate 2a to shut down Ras signals in fibroblasts. We report an alternative mechanism by which PEA-15 can activate ERK through direct activation of PLD1, which leads to activation of Ras/MAPK signaling upstream of ERK. We found that even under serum-starved conditions lacking any initial Ras signaling, PEA-15 is still capable of activating ERK to a similar level as Ras.
The PEA-15 binding partner PLD1 had a part in this context. PLD1 has been described previously to be involved in the regulation of many signaling pathways including the Ras-ERK pathway, thereby driving cell cycling and proliferation (Yang et al., 2001; Donaldson, 2009 ). PLD1 is activated by H-Ras and has been proven to be crucial for the transformation of rat fibroblasts by H-Ras (Buchanan et al., 2005; Shi et al., 2007) . PLD1 has been reported to regulate Ras-ERK signaling both upstream and downstream of Ras through the Overexpression of PEA-15 in iBMK cells overexpressing constitutively active H-Ras causes higher PLD1 activity either through higher PLD1 expression levels or a yet undefined activation mechanism. Subsequently, PLD1 produces increased amounts of the signaling molecule PA. PA then increases recruitment of the guanine nucleotide exchange factor SOS (1) and/or the kinase Raf (2) to the plasma membrane. H-Ras is constitutively bound to the plasma membrane and is immediately able to induce higher signaling rates upon guanosine triphosphate loading. This leads to the observed downstream effects, such as increased ERK activity and cell cycle progression. In this scenario, PEA-15 is phosphorylated at Ser116. Unphosphorylated PEA-15 (3) is able to bind ERK and sequester it in the cytoplasm as previously reported.
PEA-15 enhances H-Ras-mediated cell transformation FJ Sulzmaier et al generation of PA. PA is crucial for epidermal growth factor-induced activation of Ras because of its recruitment of the guanine nucleotide exchange factor SOS to the plasma membrane (Hancock, 2007) . However, PA seems to also exert effects downstream of Ras where it is necessary to allow Ras binding to Raf-1 (Rizzo et al., 2000) . Both studies show that PLD1 is an important cofactor in Ras-MAPK signaling and acts as a positive regulator.
We observed higher levels of PLD1 upon overexpression of PEA-15 in iBMK cells. This may have been due to a stabilization of PLD1 levels by PEA-15 as previously described (Zhang et al., 2000) . In iBMK cells, PEA-15 and PLD1 show co-localization. PEA-15 colocalizes with PLD1 in the nucleus and in perinuclear regions, and upon H-Ras co-expression also in regions at the cell membrane. Additionally, overexpression of PEA-15 or H-Ras increased PLD1 activity. Possibly due to the increased levels of protein, PLD1 activity was higher when both H-Ras and PEA-15 were expressed as compared with overexpression of H-Ras alone.
To assess the involvement of PLD1 in H-Rasmediated transformation in iBMK cells, we used two different inhibitor approaches. We blocked PLD1 catalytic activity with the commonly used but less specific inhibitor n-butanol, and also looked at the effects of a PLD1-specific inhibitor VU 0155069. This potent small-molecule inhibitor has been described to selectively inhibit the PLD1 isoform (Scott et al., 2009) . We analyzed phosphorylation of ERK as a major transforming signaling pathway in these cells (Tan et al., 2005) and used it as a readout after interfering with PLD1 catalytic activity. Treatment of iBMK cells with inhibitors of PLD1 hydrolytic activity blocked ERK phosphorylation upon both H-Ras and H-Ras/PEA-15 co-overexpression, resulting in up to a 60% decrease in ERK activity. PLD1 inhibition in this experiment only slightly reduced the viability of the cells. A loss of PLD1 catalytic activity also resulted in inhibition of soft agar growth. Neither H-Ras nor H-Ras/PEA-15 co-expressing cells formed colonies after pretreatment with the specific PLD1 inhibitor. We further analyzed the involvement of PLD1 by putting special focus on its binding to PEA-15. We used the PLD1-D4 domain as a mutant construct that specifically keeps functional endogenous PLD1 from binding to . This allowed us to analyze the importance of this protein interaction for the activation of ERK in the iBMK system. Co-expression of mutant PLD1-D4 blocked the increase of pERK upon H-Ras and PEA-15 coexpression, further confirming the necessity of functional PLD1 and an intact PLD1-PEA-15 interaction for PEA-15 0 s ability to increase H-Ras mediated ERK activation.
On the basis of our findings and previous reports, PEA-15 could act at least in part through two different ways to enhance H-Ras-mediated cell transformation through PLD1 (Figure 8d ). Overexpression of PEA-15 results in higher PLD1 activity, which leads to increased amounts of the signaling molecule PA. Elevated signaling through PA can enhance levels of the guanine nucleotide exchange factor SOS recruited to the plasma membrane as described by Hancock (2007) . H-Ras is bound to the plasma membrane and activated upon guanosine triphosphate loading by SOS (Figure 8d , no. 1). Alternatively, increased PA can result in a higher recruitment of the kinase Raf to the membrane and enhance Ras-Raf binding (Figure 8d, no. 2) as previously shown by Rizzo et al. (2000) . Both mechanisms can lead to the observed downstream effects and result in elevated ERK activity. Although both pathways are possible, an enhancement of Ras-MAPK signaling at the Raf level seems more likely in our study. Transfected oncogenic H-Ras G12V already is constitutively active, making further enhancement of the signaling cascade by PEA-15 upstream of H-Ras less likely. In the presence of oncogenic H-Ras, PEA-15 is phosphorylated at Ser116 and does not restrict ERK to the cytoplasm. Note that unphosphorylated PEA-15 has been previously shown to negatively regulate Ras-MAPK signaling by preventing ERK translocation into the nucleus (Figure 8d, no. 3; Formstecher et al., 2001; Pastorino et al., 2010) .
On the basis of these results we propose a novel function of PEA-15 in enhancing H-Ras-driven transformation. This effect was also observed in an in vivo mouse model, where PEA-15 co-expression promoted earlier and larger tumor formation. H-Ras-activating mutations are common among various kinds of human malignancies, and about 30% of human cancers show mutations in the Ras gene that cause the gene product to be constitutively active (Dunn et al., 2005) . Additionally, other common mutations in tumors, such as activating epidermal growth factor receptor mutations, can induce increased H-Ras activity as shown in human RCCs (Barrett et al., 2009) . Interestingly, these tumors also show elevated PEA-15 expression levels compared with normal kidney tissues, mainly in clear cell RCC (Figures 8b and c) . Renal Wilms' tumor or Ewing sarcoma, tumors in which no Ras mutations are involved in the pathogenesis, show only low PEA-15 expression (Figure 8c ; Waber et al., 1993; Radig et al., 1998) .
These findings together with our results in mouse kidney epithelial cells indicate that PEA-15 can potentiate tumorigenesis in the context of oncogenic Ras signaling. Thus, PEA-15 can either enhance or impair tumorigenesis depending on the signaling pathways active in the specific tumor cell.
Materials and methods

Cell lines and reagents
Parent iBMK cells were developed in the laboratory of Eileen White and described previously (Tan et al., 2005) . Stable iBMK cells expressing PEA-15, H-Ras, H-Ras and PEA-15 (HR-PEA) or the vector control were derived by electroporation with pcDNA1.H-rasV12 (Lin et al., 1995) , pIRESpuro3-PEA-15 or pcDNA3.1 (Tan et al., 2005) , followed by selection with G418 (vector control, H-Ras) or puromycin (PEA-15 and HR-PEA). For every type, three independent cell lines were generated and analyzed. Cells were grown in DMEM (Thermo Fisher Scientific Inc., Waltham, MA, USA) supplemented with 4 mM L-glutamine, 10% fetal bovine serum, nonessential amino acids, penicillin/streptomycin and 800 mg/ml G418 or 10 mg/ml puromycin. The successful transfection was further confirmed by western blotting. In addition, iBMK cells carrying the vector control pcDNA3.1 were transiently transfected with the constructs mentioned above using Lipofectamine (Invitrogen, Carlsbad, CA, USA) as described by the manufacturer's protocol. For suspension cultures, cells were harvested and plated on cell culture dishes coated with 3% agarose for the indicated amount of time. Antibodies used were specific for H-Ras ( Western blotting Cells were cultured as described. After 48 h of incubation, cells were lysed with ice-cold M2 buffer as previously described . Cell lysate protein was resolved by SDSpolyacrylamide gel electrophoresis. Expression and phosphorylation of proteins were determined by western blotting using specific antibodies. Binding of primary antibodies was detected using either horseradish peroxidase-conjugated secondary antibodies (Cell Signaling) or IRDye 680 goat anti-mouse and IRDye 800 goat anti-rabbit antibodies (Li-Cor Biosciences, Lincoln, NE, USA). Bands were visualized by autoradiography after incubation with enhanced chemiluminescence reagents (PerkinElmer, Waltham, MA, USA) or detected using an Odyssey Infrared Imaging System (Li-Cor Biosciences, Lincoln, NE, USA). Scanned blots were cropped to improve clarity and conciseness of presentation using Adobe Photoshop CS (Adobe Systems Inc., San Jose, CA, USA).
Soft agar colony formation assay
Equal cell numbers (1 Â 10 4 ) of each stably transfected iBMK cell line were cultured for 14 days suspended in Dulbecco's modified Eagle's Medium (DMEM) in a 0.3 % agar solution on agar (0.6% in DMEM)-coated culture plates. Formed colonies in the soft agar assay were counted and analyzed using a BioRad imager and Quantity One software v4.6 (Bio-Rad, Hercules, CA, USA). For the inhibitor assay, cells were preincubated with 50 mM VU 0155069 for 30 min and an equal inhibitor concentration was added to the soft agar solution.
Cell cycle analysis and viability assay Equal numbers of iBMK cells (2 Â 10 5 ) from each cell line were plated on agarose-coated dishes to keep the cells in suspension. Cells were cultured for 48 h as described above. Subsequently, cells were fixed in 70 % EtOH and stained in permeabilization buffer containing 100 mg/ml propidium iodide, 50 mg/ml RNAase and 0.2% Triton X. For the viability assay, cells were cultured as indicated and stained with propidium iodide. Cells were analyzed using a FASCcan flow cytometer and CellQuest software (Becton Dickinson, San Jose, CA, USA).
Each cell line was examined in triplicate, and for each measurement approximately 20 000 cells were analyzed.
mRNA expression analysis iBMK cells carrying the vector control pcDNA3.1 were transiently transfected with 2 mg of H-Ras, PEA-15 or both constructs. At 48 h after transfection, cells were harvested, plated on agarose-coated dishes (to prevent adherence) and incubated for 18 h. Samples were lysed with Qiagen RLT lysis buffer (Qiagen Inc., Valencia, CA, USA). The lysates were homogenized using QIAShredder columns (Qiagen). RNA was extracted using Qiagen's RNeasy Mini kit according to the manufacturer's protocol. RNA integrity was assessed on RNA Nano 6000 chips and 2100 Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). RNA was converted to complementary DNA (cDNA) using the High Capacity cDNA RT Kit with RNase Inhibitor (Life Technologies Corporation, Carlsbad, CA, USA). cDNA levels were quantified using quantitative PCR on an HT 7900 FAST real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Quantitative PCR was performed on a 96-well plates in triplicates for the two genes of interest (CCND1 and cdk4) and -actin as housekeeping gene. Primer assays for genes of interest and housekeeping gene (CCND1 and cdk4 QuantiTect SYBRGreen assays) were purchased from Qiagen.
Immunofluorescence Each iBMK cell line was grown on glass coverslips coated with 10 mg/ml fibronectin under regular cell culture conditions as described above. When about 50% confluent, cells were fixed in 2% paraformaldehyde, permeabilized in 0.1% Triton X-100 in phosphate-buffered saline and blocked with 1% normal goat serum. Cells were stained with primary antibody against ERK1/ 2 (p44/42; Cell Signaling), PEA-15 (Santa Cruz Biotechnology, no. sc-166678) or PLD1 (Epitomics, no. 2315-1). Alexa Fluor 488, 594 and 647 secondary antibodies (Invitrogen) were used to fluorescently label bound primary. Coverslips were mounted on slides using 4 0 ,6-diamidino-2-phenylindole containing mounting medium (Vector Labs, Burlingame, CA, USA) or Fluoromount G (no. 17984-25, Electron Microscopy Sciences, Hatfield, PA, USA). Images were acquired on a Leica TCS-SP5 confocal microscope (Leica Microsystems, Buffalo Grove, IL, USA) using a Â 62 oil immersion objective or a Zeiss Axiovert 100 M fluorescent microscope using a Â 100 oil-immersion objective and Zeiss AvioVision acquisition software (Carl Zeiss MicroImaging Inc., Thornwood, NY, USA).
PLD1 activity assay
Transiently transfected iBMK cells carrying the vector control pcDNA3.1 were lysed by three freeze and thaw cycles in icecold Tris (50 mM, pH 8.0). PLD activity was measured using the Amplex Red Phospholipase D Assay Kit (Invitrogen) following the manufacturer's protocol.
Tumor formation in nude mice
Tumor formation in nude mice was performed as previously described (Streit et al., 1999) . In brief, equal cell numbers of each iBMK cell line were injected subcutaneously in the abdominal region of 6-week-old nude mice (Taconic, Germantown, NY, USA). We used five mice for each iBMK cell line and followed tumor growth for 60 days. Tumor growth was monitored weekly by measurements with a 6-inch dial caliper (General Tools Mfg Co., New York, NY, USA). Mice were killed once the tumor had reached 500 mm 2 size. All
